HAE: Rega marang dodolan Haemonetics Corp

Simbol lan logo merek Haemonetics Corp (HAE)

Haemonetics Corporation (HAE) maintains a leading position in the blood processing niche, leveraging patent protection and stringent government regulation. The current P/S multiple on the GURU.Markets daily chart reflects the valuation trend, where 4.00 is the current value of the indicator. Stable management has successfully diversified the device portfolio, while Christopher Simon's strategy to implement high-margin plasmapheresis technologies ensures profitability growth.

HAE (Haemonetics) riwayat Multiplikator P/S saka 04.07.2022 nganti 13.11.2026

Rincian analitis perusahaan Haemonetics Corp. (HAE)

- rega pasar lan target rega analis:
Kutipan saham haemonetics.com|HAE - Prakiraan konsensus analis
- informasi kapitalisasi pasar:
Nilai pasar Haemonetics Corp.|HAE - Nilai Perusahaan
- data nilai buku modal saham:
Ekuitas saben Saham Haemonetics|HAE - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku haemonetics.com|HAE - Total Aset Perusahaan
- statistik kawajiban utang lan likuiditas:
Rasio Total Utang marang Ekuitas Haemonetics Corporation|HAE - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Haemonetics Company|HAE - Utang perusahaan|Rasio utang marang kapitalisasi buku Haemonetics Corp.|HAE - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Haemonetics|Likuiditas darurat haemonetics.com
- indikator pendapatan resik lan kelipatan nilai:
HAE - Bathi resik perusahaan|Proyeksi bathi resik Haemonetics Corporation|HAE - Koefisien rega marang bathi|Pangali Forward P/E Haemonetics Corp|HAE - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Haemonetics Corp.|HAE - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan Haemonetics|HAE - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan haemonetics.com|HAE - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Haemonetics Corporation
- rincian pendapatan lan dodolan emiten:
HAE - Pendapatan perusahaan|Prakiraan pendapatan perusahaan haemonetics.com|HAE - Kapitalisasi marang pendapatan|Rasio rega marang pendapatan sing dikarepake Haemonetics Corp.
Analisis fundamental perusahaan:haemonetics.com HAE
Produk asli Haemonetics Corp.

The investment appeal of Haemonetics Corporation (HAE) is based on its status as a global technological leader in transfusion medicine and the high level of trust it maintains with medical centers. By analyzing the price-to-sales multiple on the GURU.Markets platform, an investor compares the business's market value with its annual revenue, allowing for an objective assessment of whether the asset is overvalued relative to the company's actual cash flows.

Karo sapa Haemonetics Corporation saingan

Kapitalisasi marang pendapatan dexcom.com DXCM|Multiplikator P/S PEN (Penumbra)|Novanta Inc (NOVT) - Rega marang dodolan|Inspire Sleep - Multiplikator P/S|PRCT (Procept) - Rasio kapitalisasi marang pendapatan|CNMD: Multiplikator P/S|PLSE - Koefisien rega marang pendapatan|INMD (InMode) - Multiplikator P/S|Kapitalisasi marang pendapatan Picard Medical Corp (PMI)|Multiplikator P/S SRDX|Multiplikator P/S Eversense (SENS)|Rasio rega marang pendapatan NeuroPace, Inc. NPCE|Tactile Systems Technology, Inc. - Rasio rega marang pendapatan|SNWV: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan OM (Outset Medical Inc)|ELMD: Multiplikator P/S|Rega marang dodolan LENSAR Inc (LNSR)|Rasio rega marang pendapatan AVITA Medical, Inc.|PROF - Multiplikator rega marang pendapatan|Kapitalisasi marang pendapatan BDMD (Baird Medical Investment)|Multiplikator P/S edap-tms.com (EDAP)|Multiplikator P/S APYX (Apyx Medical Corporation)|Koefisien rega marang pendapatan IceCure Medical Ltd. (ICCM)|LUNG - Rasio rega marang pendapatan|Rasio rega marang dodolan TELA|cytosorbents.com (CTSO) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan Sensus Healthcare Inc|ZYXI (Zynex Inc) - Multiplikator P/S|Rega marang dodolan electroCore Medical ECOR|Rasio rega marang pendapatan Vicarious Surgical Inc. (RBOT)|inspira-technologies.com - Rasio kapitalisasi marang pendapatan|SeaStar Medical - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan IRIX (IRIDEX Corp)|Intelligent Bio - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan XAIR (Beyond Air, Inc.)|PFSA: Multiplikator P/S|STRATA Skin Sciences, Inc. (SSKN) - Multiplikator P/S|GCTK (GlucoTrack, Inc.) - Multiplikator P/S|Rega marang dodolan nanovibronix.com NAOV|Rasio rega marang pendapatan Venus Concept Corp (VERO)|Kapitalisasi marang pendapatan Nuwellis Corp NUWE|Rasio rega marang pendapatan Aethlon Medical AEMD|Asensus Surgical Inc (ASXC) - Rega marang dodolan|AVGR - Rasio rega marang pendapatan|BSGM (BioSig) - Rasio kapitalisasi marang pendapatan|CUTR: Multiplikator P/S|Rega marang dodolan Know Labs Corporation (KNW)|Kapitalisasi marang pendapatan NARI|NVRO (nevro.com) - Kapitalisasi marang volume dodolan|Multiplikator P/S RSLS|Koefisien rega marang pendapatan Silk Road Medical, Inc.